{"id":1523,"date":"2022-06-10T14:20:39","date_gmt":"2022-06-10T17:20:39","guid":{"rendered":"https:\/\/new-website.wecann.academy\/2022\/06\/10\/are-there-benefits-of-medical-cannabis-in-the-treatment-of-the-injured-brain-following-a-traumatic-brain-injury\/"},"modified":"2025-10-19T23:31:07","modified_gmt":"2025-10-20T02:31:07","slug":"are-there-benefits-of-medical-cannabis-in-the-treatment-of-the-injured-brain-following-a-traumatic-brain-injury","status":"publish","type":"post","link":"https:\/\/wecann.academy\/en\/are-there-benefits-of-medical-cannabis-in-the-treatment-of-the-injured-brain-following-a-traumatic-brain-injury\/","title":{"rendered":"Are there benefits of medical Cannabis in the treatment of the injured brain following a traumatic brain- injury?"},"content":{"rendered":"<p class=\" translation-block\"><span ><span><span style=\"color: #222222\">The <b>Traumatic brain injury (TBI)<\/b> is an important cause of death, disability, and cognitive and motor impairment in Brazil and worldwide. Besides the lack of a wide range of drugs available to treat motor and cognitive sequelae after a TBI, the refractivity of patients to the usual therapeutic arsenal makes it necessary to search for new prescription strategies.<\/p>\n<p class=\" translation-block\"><span ><span><span style=\"color: #222222\">Medical Cannabis stands out in this scenario due to the neuroprotective properties of <a target=\"_self\" href=\"https:\/\/wecann.academy\/fitocanabinoide\" rel=\"noopener\"><span style=\"color: #2ecc71\"><span>phytocannabinoids<\/span><\/span><\/a><span><span style=\"color: #222222\"> and the other psychotherapeutic attributes of the <a target=\"_self\" href=\"https:\/\/wecann.academy\/quimiovariantes-da-cannabis\" rel=\"noopener\"><span><span style=\"color: #1155cc\"><u>\u00a0<\/u><\/span><span style=\"color: #2ecc71\">different chemovars of the plant<\/span><\/span><\/a><span><span style=\"color: #222222\">\u00a0 that have already been scientifically proven.<\/span><\/p>\n<p>Read this article to the end to discover the scientific evidence for the benefits of medical Cannabis use in the treatment of injured brain following a traumatic brain injury and be up to date on it!<\/p>\n<h2>Endocannabinoid system and neuroprotective actions<\/h2>\n<p class=\" translation-block\"><span ><span><span style=\"color: #000000\">As we know, the <a target=\"_self\" href=\"https:\/\/wecann.academy\/sistema-endocanabinoide\" rel=\"noopener\"><span style=\"color: #2ecc71\"><span>Endocannabinoid System<\/span><\/span><\/a><span><span style=\"color: #000000\"> modulates and regulates an extensive range of physiological processes, such as inflammatory processes, synaptic plasticity, learning and memory processes, movement coordination, the sleep-wake cycle, and even body temperature regulation.<\/span><\/span><\/p>\n<p class=\" translation-block\"><span ><span><span style=\"color: #222222\">In traumatic brain injuries, preclinical studies show the neuroprotective role of SEC <b>in reducing sequelae following brain injury.<\/b><\/p>\n<p class=\" translation-block\"><span ><span><span style=\"color: #222222\">This <a target=\"_self\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28261100\/\" rel=\"noopener\"><span> <span style=\"color: #2ecc71\">North American study<\/span><\/span><\/a><span><span style=\"color: #222222\"> highlights the neuroprotective properties of endocannabinoids by pointing out the increase in plasma concentrations of <b>anandamide<\/b> and <b>2-araquidonylglycerol (2-AG)<\/b> in response to brain injury, suggesting that the <b>SEC plays a central regulatory role in compensatory and repair mechanisms to neuronal injury.<\/b><\/span><\/span><\/p>\n<p><strong> Read the full study at:\u00a0<\/strong><\/span><\/span><a target=\"_blank\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28261100\/\" rel=\"noopener\"><span><span><strong>Endocannabinoids: A Promising Impact for Traumatic Brain Injury<\/strong><\/span><\/span><\/a><\/span><\/p>\n<p class=\" translation-block\"><span ><span><span style=\"color: #222222\">Following the same line of research, this paper published in the <a target=\"_self\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30489198\/\" rel=\"noopener\"><span> <span style=\"color: #2ecc71\">Journal of Neurotrauma<\/span><\/span><\/a><span><span style=\"color: #222222\"> shows that the <b>endocannabinoid 2-AG<\/b> binds to the cannabinoid receptors <b>CB1<\/b> and <b>CB2<\/b> about one hour after the traumatic brain injury in animal models, and it is able to attenuate neurological deficits resulting from the injury by <b>reducing neuroinflammation, brain edema formation, extent of ischemic area, blood-brain barrier permeability, as well as reducing neuronal cell loss.<\/b><\/span><\/span><\/p>\n<p><strong> You can read the full study here:<\/strong><\/span><\/span><a target=\"_blank\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30489198\/\" rel=\"noopener\"><span><span><strong>Role of CB 2 Receptor in the Recovery of Mice after Traumatic Brain Injury<\/strong><\/span><\/span><\/a><span><span>.<\/p>\n<p>As we know, endogenous endocannabinoid release is not always sufficient to prevent post- TBI neuronal damage. However, the SEC can also be activated and modulated by external cannabinoid substances, specially by the phytocannabinoids found in the Cannabis plant.<\/p>\n<h2>Medical Cannabis and traumatic brain injury<\/h2>\n<p>Like the endocannabinoids, the phytocannabinoids <\/span><\/span><a target=\"_blank\" href=\"https:\/\/wecann.academy\/en\/fitocanabinoide\/\" rel=\"noopener\"><span><span>CBD,<\/span><\/span><\/a><span><span> and <\/span><\/span><a target=\"_blank\" href=\"https:\/\/wecann.academy\/en\/atributos-medicinais-do-thc\/\" rel=\"noopener\"><span><span>THC<\/span><\/span><\/a><span><span> also exhibit neuroprotective properties and are able to <strong>minimize the adverse outcomes of brain injury<\/strong>by protecting neurons from the different injuries underlying neuronal injury, such as <strong>excitotoxicity, excessive free radical release, and exacerbated neuroinflammatory response.<\/strong>.<\/p>\n<p>As it could be demonstrated <\/span><span style=\"color: #2ecc71;\">in<\/span><\/span><a target=\"_blank\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26845349\/\" rel=\"noopener\"><span><span>this bibliographic review<\/span><\/span><\/a><span><span> that reinforces the neuroprotective role of <strong>Cannabidiol,<\/strong> by facilitating the synaptic plasticity and neurogenesis.\u00a0<\/p>\n<p><strong> Check out the full study at:<\/strong>\u00a0<\/span><\/span><a target=\"_blank\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26845349\/\" rel=\"noopener\"><span><span><strong>Cannabidiol, neuroprotection and neuropsychiatric disorders<\/strong><\/span><\/span><\/a><\/span><\/p>\n<p>\u00a0<\/p>\n<p>This<\/span><\/span><a target=\"_blank\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25264643\/\" rel=\"noopener\"> <span><span>comparative study<\/span><\/span><\/a><span><span> covers the use of <\/span><\/span><a target=\"_blank\" href=\"https:\/\/wecann.academy\/en\/atributos-medicinais-do-thc\/\" rel=\"noopener\"><span><span><strong>THC<\/strong><\/span> <\/span><\/a><span><span>and its relationship with adverse events related to traumatic brain injury. This is a three-year analysis, which showed that the use of THC was associated with a lower chance of death from traumatic brain injury.<\/p>\n<p>Interestingly, in a sample consisting of 446 patients, the mortality rate in the group that used THC was <strong>2,4%<\/strong>while in the group that did not use this phytocannabinoid, the mortality rate was <strong>11,5%<\/strong>.<\/p>\n<p><strong> You can read the full study here:<\/strong><\/span><\/span><a target=\"_blank\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25264643\/\" rel=\"noopener\"><span><span><strong>Effect of marijuana use on outcomes in traumatic brain injury<\/strong><\/span><\/span><\/a><span><span><strong>.<\/strong><\/p>\n<p>\u00a0<\/p>\n<p>Although many observational studies and pre-clinical research on the relationship between medical Cannabis and TBI are still under development, it is already possible to infer a number of benefits of this therapeutic in the treatment of brain injuries.<\/p>\n<p><strong> Check out more on this topic at: <\/strong><\/span><\/span><a target=\"_blank\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8001020\/pdf\/ijms-22-02992.pdf\" rel=\"noopener\"><span><span><strong>Cannabidiol and Other Cannabinoids in Demyelinating Diseases<\/strong><\/span><\/span><\/a><\/span><\/p>\n<p>As medical Cannabis consolidates as a legal practice, freeing itself from social and cultural stigmas, studies are gaining more methodological quality, so that its use can be increasingly assertive.<\/p>\n<p>It is also important to emphasize that <\/span><\/span><a target=\"_blank\" href=\"https:\/\/wecann.academy\/en\/educacao-em-cannabis-medicinal\/\" rel=\"noopener\"><span><span>\u00a0<\/span><span style=\"color: #2ecc71;\">specialized education<\/span><\/span><\/a><span><span> in the area is fundamental to act safely and effectively in prescriptive practice, optimizing therapeutic results and avoiding potential adverse effects.<\/p>\n<p>\u00a0<\/p>\n<p>The <strong>WeCann Academy<\/strong> is committed to your learning journey. We connect experts from around the world in a global study community in Endocannabinoid Medicine to bridge scientific knowledge and practical experience in the medical use of Cannabis.<\/p>\n<p>\u00a0<\/p>\n<p>Do you want to join our community?<\/span><\/span><a target=\"_blank\" href=\"https:\/\/wecann.academy\/en\/contato\/\" rel=\"noopener\"><span><span>Contact us<\/span><\/span><\/a><span><span> and get ready for the new frontier of the Medicine!<\/p>\n<p><span style=\"font-size: 11pt;\"><span><span>\u00a0<\/p>\n<p><strong>References<\/strong><\/p>\n<p>Campos AC, Foga\u00e7a MV, Sonego AB, Guimar\u00e3es FS.<\/span><\/span><a target=\"_blank\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26845349\/\" rel=\"noopener\"> <span><span>Cannabidiol, neuroprotection and neuropsychiatric disorders<\/span><\/span><\/a><span style=\"color: #7a7a7a;\"><span>. Pharmacol Res. 2016.<\/p>\n<p>DeMesa J, Garc\u00eda-Mart\u00edn A, Mu\u00f1oz E, Navarrete C, Rolland A. <\/span><\/span><a target=\"_blank\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8001020\/\" rel=\"noopener\"><span><span>Cannabidiol and Other Cannabinoids in Demyelinating Diseases.<\/span><\/span><\/a><span style=\"color: #7a7a7a;\"><span> Int J Mol Sci. 2021.<\/p>\n<p>Magid L, Heymann S, Elgali M, Avram L, Cohen Y, Liraz-Zaltsman S, Mechoulam R, Shohami E.<\/span><\/span><a target=\"_blank\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30489198\/\" rel=\"noopener\"> <span><span>Role of CB2 Receptor in the Recovery of Mice after Traumatic Brain Injury<\/span><\/span><\/a><span><span>.<\/span><\/span><span style=\"color: #7a7a7a;\"><span> J Neurotrauma. 2019.<\/p>\n<p>Nguyen BM, Kim D, Bricker S, Bongard F, Neville A, Putnam B, Smith J, Plurad D.<\/span><\/span><a target=\"_blank\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25264643\/\" rel=\"noopener\"> <span><span>Effect of marijuana use on outcomes in traumatic brain injury<\/span><\/span><\/a><span><span>.<\/span><\/span><span style=\"color: #7a7a7a;\"><span> Am Surg. 2014.<\/p>\n<p>Schurman LD, Lichtman AH. Endocannabinoids:<\/span><\/span><a target=\"_blank\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28261100\/\" rel=\"noopener\"> <span><span>A Promising Impact for Traumatic Brain Injury<\/span><\/span><\/a><span><span>.<\/span><\/span><span style=\"color: #7a7a7a;\"><span> Front Pharmacol. 2017.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Traumatic brain injury (TBI) is an important cause of death, disability, and cognitive and motor impairment in Brazil and worldwide. Besides the lack of a wide range of drugs available to treat motor and cognitive sequelae after a TBI, the refractivity of patients to the usual therapeutic arsenal makes it necessary to search for [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1411,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1523","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sem-categoria"],"acf":[],"_links":{"self":[{"href":"https:\/\/wecann.academy\/en\/wp-json\/wp\/v2\/posts\/1523","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wecann.academy\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wecann.academy\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wecann.academy\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/wecann.academy\/en\/wp-json\/wp\/v2\/comments?post=1523"}],"version-history":[{"count":4,"href":"https:\/\/wecann.academy\/en\/wp-json\/wp\/v2\/posts\/1523\/revisions"}],"predecessor-version":[{"id":3533,"href":"https:\/\/wecann.academy\/en\/wp-json\/wp\/v2\/posts\/1523\/revisions\/3533"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wecann.academy\/en\/wp-json\/wp\/v2\/media\/1411"}],"wp:attachment":[{"href":"https:\/\/wecann.academy\/en\/wp-json\/wp\/v2\/media?parent=1523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wecann.academy\/en\/wp-json\/wp\/v2\/categories?post=1523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wecann.academy\/en\/wp-json\/wp\/v2\/tags?post=1523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}